We’re thrilled that such a respected organization as JEMS has validated these efforts and endorsed T-PODResponder as one of the top products for 2014 in the EMS market.
Vancouver, BC (PRWEB) June 25, 2014
Pyng Medical Corp. (PYT:TSX.V), an award-winning developer of trauma and resuscitation products for emergency, combat and critical care personnel, announces that its new T-PODResponder Pelvic Stabilization Device was awarded the Hot Products title for 2014 by the Journal of Emergency Medical Services (JEMS). The award recognizes the best new products for emergency medical services (EMS) launched within the eight months prior to the EMS Today Conference, which was held in Washington, DC on February 6-8, 2014.
“Our medical and engineering team at Pyng worked hard to develop a new pelvic stabilization product that took the well-accepted features of the original T-POD device and enhanced them to better meet the specific needs of first responders in the field,” said Pyng CEO Mark Hodge. “We’re thrilled that such a respected organization as JEMS has validated these efforts and endorsed T-PODResponder as one of the top products for 2014 in the EMS market.”
T-PODResponder, the newest pelvic stabilization device from Pyng Medical, provides EMS personnel with the critical ability to quickly and easily stabilize the pelvic ring in patients that have suspected pelvic fractures and possible internal bleeding. T-PODResponder can be quickly applied in the field by one person using an easy-to-tighten pulley system. With a highly flexible design, T-PODResponder is small and compact, is one-size-fits-all, and can remain on through MRI, X-Ray and CT scans.
Additional benefits of T-PODResonder include:
- 100% radiolucent. T-PODResponder is designed without the use of metal so it does not have to be removed for MRI, X-Ray and CT scans.
- Compact and lightweight design to better fit into your emergency bag.
- Using a unique mechanical advantage pulley system, T-PODResponder ensures simultaneous, symmetrical compression, where and when needed—placing control of the tightening process in the hands of providers.
- Early pre-hospital pelvic immobilization using T-PODResponder reduces morbidity, mortality, blood loss, the need for blood transfusions and hospital length of stay.
To learn more about the Hot Products Awards, download the PDF at http://www.jems.com/sites/default/files/HotProdcuts_0.pdf or visit the JEMS Hot Products issue web page at: http://www.jems.com/magazines/2014/june. For more information on T-PODResponder, visit go.pyng.com/t-podresponder.
About Pyng Medical Corp.
Pyng Medical Corp. engineers and markets award-winning trauma and resuscitation products for front-line critical care personnel world-wide. Pyng’s product portfolio includes innovative sternal intraosseous (sternal IO) pelvic stabilization and tourniquet devices specifically designed and customized for both the military and civilian markets. With growing markets in North America, Europe and Asia, Pyng develops user-preferred medical devices for use by hospital staff, emergency medical services and military forces worldwide.
For More Information:
Chief Financial Officer
Pyng Medical Corp.
(604) 303-7964 x219
Neither the TSX Venture Exchange nor its Regulatory Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Safe Harbour Statement; Forward-Looking Statements: This release may contain forward-looking statements based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking statements may be identified by words like "expects", "anticipates", "plans", "intends", "projects", "indicates", and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in documents which may be filed with the British Columbia Securities Commission, the Alberta Securities Commission, the TSX Venture Exchange, as well as other USA Commissions, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies and economic conditions, including inflation, interest and foreign currency exchange rates, of countries in which the Company does business; competitive pressures; successful integration of structural changes, including restructuring plans, acquisitions, divestitures and alliances; cost of raw material, research and development of new products, including regulatory approval and market acceptance; and seasonality of sales in some products.